Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

sTErnAl heMostasiS Trial (TEAMS Trial)

NCT06511778 is registered in ClinicalTrials.gov with WakeMed Health and Hospitals as lead sponsor.

NCT NCT06511778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06511778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
sTErnAl heMostasiS Trial (TEAMS Trial)
Lead sponsor
WakeMed Health and Hospitals
Phase
Phase 4
Overall status
Recruiting
Start date
October 17, 2024
Completion date
September 30, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

excessive bleeding during surgery